J.J. Jager

Impact of a Higher Radiation Dose on Local Control and Survival in Breast-Conserving Therapy of Early Breast Cancer: 10-Year Results of the Randomized Boost Versus No Boost EORTC 22881-10882 Trial

Harry Bartelink, Jean-Claude Horiot, Philip Poortmans et al. · Journal of Clinical Oncology · 2007 · 1K citations

Medicine, Oncology, Radiation Oncology +17

Recurrence Rates after Treatment of Breast Cancer with Standard Radiotherapy with or without Additional Radiation

Harry Bartelink, Jean-Claude Horiot, Philip Poortmans et al. · New England Journal of Medicine · 2001 · 951 citations

Medicine, Oncology, Radiation Oncology +13

A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) study 22844

Abul B.M.F. Karim, B. Maat, Reidulv Hatlevoll et al. · International Journal of Radiation Oncology*Biology*Physics · 1996 · 703 citations

Medicine, Oncology, Radiation Oncology +16

Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial

Harry Bartelink, P. Maingon, Philip Poortmans et al. · The Lancet Oncology · 2014 · 682 citations

Medicine, Oncology, Radiation Oncology +15

The influence of patient, tumor and treatment factors on the cosmetic results after breast-conserving therapy in the EORTC ‘boost vs. no boost’ trial

Conny Vrieling, Laurence Collette, Alain Fourquet et al. · Radiotherapy and Oncology · 2000 · 319 citations

Medicine, Oncology, Radiation Oncology +13